These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22143936)

  • 21. HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison.
    Koopman T; Smits MM; Louwen M; Hage M; Boot H; Imholz AL
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1343-51. PubMed ID: 25544671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human epidermal growth factor receptor 2 (HER-2) status evaluation in advanced gastric cancer using immunohistochemistry versus silver in situ hybridization.
    Kepil N; Batur S; Sonmez Wetherilt C; Erdamar Cetin S
    Bosn J Basic Med Sci; 2017 May; 17(2):109-113. PubMed ID: 27579854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low frequency of HER2 amplification and overexpression in early onset gastric cancer.
    Moelans CB; Milne AN; Morsink FH; Offerhaus GJ; van Diest PJ
    Cell Oncol (Dordr); 2011 Apr; 34(2):89-95. PubMed ID: 21394646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HER2 gene and HER2 protein status and chromosome 17 polysomy in gastric cancer cells in own material.
    Ciesielski M; Kruszewski WJ; Śmiałek U; Walczak J; Szajewski M; Szefel J; Wydra J; Kawecki K
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):113-7. PubMed ID: 25203430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma.
    Yan SY; Hu Y; Fan JG; Tao GQ; Lu YM; Cai X; Yu BH; Du YQ
    World J Gastroenterol; 2011 Mar; 17(11):1501-6. PubMed ID: 21472111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Helicobacter pylori a poor prognostic factor for HER-2 SISH positive gastric cancer?
    Selcukbiricik F; Tural D; Erdamar S; Buyukunal E; Demirelli F; Serdengecti S
    Asian Pac J Cancer Prev; 2013; 14(5):3319-22. PubMed ID: 23803123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
    Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
    Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancers.
    Zhou F; Qiu W; Sun L; Xiang J; Sun X; Sui A; Ding A; Yue L
    APMIS; 2013 Jul; 121(7):582-91. PubMed ID: 23489260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of vimentin expression and Her-2 status in patients with gastric carcinoma.
    Zhao W; Yue L; Zhou F; Xu C; Liang W; Sui A; Ding A; Qiu W
    Clin Transl Sci; 2013 Jun; 6(3):184-90. PubMed ID: 23751022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Her-2/neu assessment for gastric carcinoma: validation of scoring system.
    Mrklic I; Bendic A; Kunac N; Bezic J; Forempoher G; Durdov MG; Karaman I; Prusac IK; Pisac VP; Vilovic K; Tomic S
    Hepatogastroenterology; 2012; 59(113):300-3. PubMed ID: 22260838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of HER2 Positivity and Its Clinicopathological Correlation in Locally Advanced/Metastatic Gastric Cancer Patients in Malaysia.
    Rajadurai P; Fatt HK; Ching FY
    J Gastrointest Cancer; 2018 Jun; 49(2):150-157. PubMed ID: 28124769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study.
    Prins MJ; Ruurda JP; van Diest PJ; van Hillegersberg R; Ten Kate FJ
    Ann Oncol; 2013 May; 24(5):1290-7. PubMed ID: 23334118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
    Harbeck N; Ross JS; Yurdseven S; Dettmar P; Pölcher M; Kuhn W; Ulm K; Graeff H; Schmitt M
    Int J Oncol; 1999 Apr; 14(4):663-71. PubMed ID: 10087312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models.
    Chen H; Ye Q; Lv J; Ye P; Sun Y; Fan S; Su X; Gavine P; Yin X
    Pathol Oncol Res; 2015 Sep; 21(4):947-55. PubMed ID: 25749810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
    Park YS; Hwang HS; Park HJ; Ryu MH; Chang HM; Yook JH; Kim BS; Jang SJ; Kang YK
    Hum Pathol; 2012 Mar; 43(3):413-22. PubMed ID: 21855114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.
    Park DI; Kang MS; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Han WK; Kim H; Ryu SH; Sepulveda AR
    Int J Colorectal Dis; 2007 May; 22(5):491-7. PubMed ID: 16947041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis.
    Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y
    Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction.
    Kim MA; Jung EJ; Lee HS; Lee HE; Jeon YK; Yang HK; Kim WH
    Hum Pathol; 2007 Sep; 38(9):1386-93. PubMed ID: 17555797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer.
    Chon HJ; Kim HR; Shin E; Kim C; Heo SJ; Lee CK; Park JK; Noh SH; Chung HC; Rha SY
    Ann Surg Oncol; 2015 Nov; 22(12):3938-45. PubMed ID: 25707491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?
    Sauer T; Wiedswang G; Boudjema G; Christensen H; Karesen R
    APMIS; 2003 Mar; 111(3):444-50. PubMed ID: 12752225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.